Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Chronic Heart Failure

  Free Subscription


18.06.2018

4 Am Heart J
1 Basic Res Cardiol
1 Circ Res
5 Eur J Heart Fail
1 Heart
11 Int J Cardiol
3 J Am Coll Cardiol
2 J Card Fail
1 J Cardiol
1 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am Heart J

  1. CAINZOS-ACHIRICA M, Rebordosa C, Vela E, Cleries M, et al
    Challenges of evaluating chronic heart failure and acute heart failure events in research studies using large health care databases.
    Am Heart J. 2018;202:76-83.
    PubMed     Text format     Abstract available

  2. AHMAD FS, French B, Bowles KH, Sevilla-Cazes J, et al
    Incorporating patient-centered factors into heart failure readmission risk prediction: A mixed-methods study.
    Am Heart J. 2018;200:75-82.
    PubMed     Text format     Abstract available

  3. LUO N, Ballew NG, O'Brien EC, Greiner MA, et al
    Early impact of guideline publication on angiotensin-receptor neprilysin inhibitor use among patients hospitalized for heart failure.
    Am Heart J. 2018;200:134-140.
    PubMed     Text format     Abstract available

  4. JALNAPURKAR S, Zhao X, Heidenreich PA, Bhatt DL, et al
    A Hospital Level Analysis of 30-Day Readmission Performance for Heart Failure Patients and Long-Term Survival: Findings from Get With The Guidelines-Heart Failure.
    Am Heart J. 2018;200:127-133.
    PubMed     Text format     Abstract available


    Basic Res Cardiol

  5. WIEDMANN F, Schulte JS, Gomes B, Zafeiriou MP, et al
    Atrial fibrillation and heart failure-associated remodeling of two-pore-domain potassium (K2P) channels in murine disease models: focus on TASK-1.
    Basic Res Cardiol. 2018;113:27.
    PubMed     Text format     Abstract available


    Circ Res

  6. DEY S, DeMazumder D, Sidor A, Foster DB, et al
    Mitochondrial ROS Drive Sudden Cardiac Death and Chronic Proteome Remodeling in Heart Failure.
    Circ Res. 2018 Jun 13. pii: CIRCRESAHA.118.312708.
    PubMed     Text format     Abstract available


    Eur J Heart Fail

  7. GRODIN JL, Testani JM, Pandey A, Sambandam K, et al
    Perturbations in serum chloride homeostasis in heart failure with preserved ejection fraction: insights from TOPCAT.
    Eur J Heart Fail. 2018 Jun 12. doi: 10.1002/ejhf.1229.
    PubMed     Text format     Abstract available

  8. SOKORELI I, Pauws SC, Riistama JM, Cleland JG, et al
    Psychosocial factors and mortality in patients with heart failure: reply.
    Eur J Heart Fail. 2018 Jun 12. doi: 10.1002/ejhf.1224.
    PubMed     Text format    

  9. NAGAI M, Dote K, Kato M
    Central command in heart failure: was there effect of hemispheric lateralization in insular cortex activation?
    Eur J Heart Fail. 2018 Jun 11. doi: 10.1002/ejhf.1233.
    PubMed     Text format    

  10. PACKER M
    Risk of heart failure in diabetic patients receiving sulfonylureas: reply.
    Eur J Heart Fail. 2018 Jun 11. doi: 10.1002/ejhf.1232.
    PubMed     Text format    

  11. BUTLER J, Vijayakumar S, Pitt B
    Need to revisit heart failure treatment guidelines for hyperkalaemia management during the use of mineralocorticoid receptor antagonists.
    Eur J Heart Fail. 2018 Jun 8. doi: 10.1002/ejhf.1217.
    PubMed     Text format    


    Heart

  12. KUMAR N
    Does the purported mortality benefit of beta-blocker therapy in heart failure with a preserved ejection fraction apply to patients without prior myocardial infarction?
    Heart. 2018;104:1135.
    PubMed     Text format    


    Int J Cardiol

  13. EMDIN M, Aimo A, Mirizzi G, Piacenti M, et al
    Is fat good for arrhythmias in ischemic heart failure? Another face of the obesity paradox.
    Int J Cardiol. 2018;265:169-170.
    PubMed     Text format    

  14. GUARRACINO F, Bertini P
    Heart rate control or tailored heart rate to improve ventriculo-arterial coupling in heart failure?
    Int J Cardiol. 2018;265:171.
    PubMed     Text format    

  15. BUONO A, Oliva F, Ammirati E
    Reduction of heart rate in patients with heart failure aiming to improve ventricular-arterial coupling.
    Int J Cardiol. 2018;265:172.
    PubMed     Text format    

  16. EGOM EE, Maher V, El Hiani Y
    Evolving use of natriuretic peptide receptor type-C as part of strategies for the treatment of pulmonary hypertension due to left ventricle heart failure.
    Int J Cardiol. 2018 Jun 2. pii: S0167-5273(18)30187.
    PubMed     Text format     Abstract available

  17. RIENSTRA M, van Veldhuisen DJ
    Atrial fibrillation is more troublesome in heart failure patients with preserved compared to those with reduced ejection fraction.
    Int J Cardiol. 2018;266:155-156.
    PubMed     Text format    

  18. JANG SY, Chae SC, Bae MH, Lee JH, et al
    Effect of renin-angiotensin system blockade in patients with severe renal insufficiency and heart failure.
    Int J Cardiol. 2018;266:180-186.
    PubMed     Text format     Abstract available

  19. SHULMAN E, Shah T, Mazori AY, Chudow JJ, et al
    Heart failure and the development of atrial fibrillation in Hispanics, African Americans and non-Hispanic Whites.
    Int J Cardiol. 2018 May 22. pii: S0167-5273(17)37213.
    PubMed     Text format    

  20. DOCHERTY KF, McMurray JJV
    Angiotensin receptor-neprilysin inhibitors: A new paradigm in heart failure with reduced ejection fraction.
    Int J Cardiol. 2018 Jun 2. pii: S0167-5273(18)31989.
    PubMed     Text format     Abstract available

  21. LEMOR A, Hernandez GA, Lee S, Patel N, et al
    Impact of end stage renal disease on in-hospital outcomes of patients with systolic and diastolic heart failure (insights from the Nationwide Inpatient Sample 2010 to 2014).
    Int J Cardiol. 2018;266:174-179.
    PubMed     Text format     Abstract available

  22. GOYAL P, Almarzooq ZI, Cheung J, Kamel H, et al
    Atrial fibrillation and heart failure with preserved ejection fraction: Insights on a unique clinical phenotype from a nationally-representative United States cohort.
    Int J Cardiol. 2018;266:112-118.
    PubMed     Text format     Abstract available

  23. LORENZONI G, Azzolina D, Lanera C, Brianti G, et al
    Time trends in first hospitalization for heart failure in a community-based population.
    Int J Cardiol. 2018 Jun 2. pii: S0167-5273(17)36730.
    PubMed     Text format     Abstract available


    J Am Coll Cardiol

  24. GREENE SJ, O'Brien EC, Mentz RJ, Luo N, et al
    Home-Time After Discharge Among Patients Hospitalized With Heart Failure.
    J Am Coll Cardiol. 2018;71:2643-2652.
    PubMed     Text format     Abstract available

  25. LICHSTEIN E, Sharma A
    Changing Endpoints for Heart Failure Studies.
    J Am Coll Cardiol. 2018;71:2653-2655.
    PubMed     Text format    

  26. WONG JA, Conen D, Van Gelder IC, McIntyre WF, et al
    Progression of Device-Detected Subclinical Atrial Fibrillation and the Risk of Heart Failure.
    J Am Coll Cardiol. 2018;71:2603-2611.
    PubMed     Text format     Abstract available


    J Card Fail

  27. SANJAY G, Jeemon P, Agarwal A, Viswanathan S, et al
    In-hospital and 3-year outcomes of heart failure patients in South India: The Trivandrum Heart Failure Registry().
    J Card Fail. 2018 Jun 6. pii: S1071-9164(18)30207.
    PubMed     Text format     Abstract available

  28. SAKAGUCHI T, Hirata A, Kashiwase K, Higuchi Y, et al
    Relationship of central venous pressure to body fluid volume status and its prognostic implication in patients with acute decompensated heart failure.
    J Card Fail. 2018 Jun 8. pii: S1071-9164(18)30209.
    PubMed     Text format     Abstract available


    J Cardiol

  29. TSUJI S, Koyama S, Taniguchi R, Fujiwara T, et al
    Nutritional status of outpatients with chronic stable heart failure based on serum amino acid concentration.
    J Cardiol. 2018 Jun 6. pii: S0914-5087(18)30142.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  30. LI X, Kuznetsova T, Cauwenberghs N, Wheeler M, et al
    Autoantibody profiling on a plasmonic nano-gold chip for the early detection of hypertensive heart disease.
    Proc Natl Acad Sci U S A. 2017 Jun 19. pii: 201621457.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Chronic Heart Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: